Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Long Term Investor Alert: Investigation of Potential Wrongdoing

San Diego, CA -- (SBWIRE) -- 09/25/2020 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Sorrento Therapeutics, Inc..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.